These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37850873)

  • 1. Amide Proton Transfer-Weighted Imaging and Multiple Models Intravoxel Incoherent Motion-Based
    Meng N; Jiang H; Sun J; Shen L; Wang X; Zhou Y; Wu Y; Fu F; Yuan J; Yang Y; Wang Z; Wang M
    J Magn Reson Imaging; 2024 Jul; 60(1):125-135. PubMed ID: 37850873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Amide Proton Transfer-Weighted Imaging for Lung Cancer Subtype and Epidermal Growth Factor Receptor: A Comparative Study With Diffusion and Metabolic Parameters.
    Meng N; Fu F; Feng P; Li Z; Gao H; Wu Y; Zhang J; Wei W; Yuan J; Yang Y; Liu H; Cheng J; Wang M
    J Magn Reson Imaging; 2022 Oct; 56(4):1118-1129. PubMed ID: 35258145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity and specificity of amide proton transfer-weighted imaging for assessing programmed death-ligand 1 status in non-small cell lung cancer: a comparative study with intravoxel incoherent motion and
    Meng N; Fu F; Sun J; Feng P; Luo Y; Wu Y; Li X; Yuan J; Yang Y; Liu H; Wang Z; Wang M
    Quant Imaging Med Surg; 2022 Sep; 12(9):4474-4487. PubMed ID: 36060584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical Exchange Saturation Transfer MRI: Capability for Predicting Therapeutic Effect of Chemoradiotherapy on Non-Small Cell Lung Cancer Patients.
    Ohno Y; Yui M; Yamamoto K; Takenaka D; Koyama H; Nagata H; Ueda T; Ikeda H; Ozawa Y; Toyama H; Yoshikawa T
    J Magn Reson Imaging; 2023 Jul; 58(1):174-186. PubMed ID: 36971493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comparative Study of Amide Proton Transfer Weighted Imaging and Intravoxel Incoherent Motion MRI Techniques Versus (18) F-FDG PET to Distinguish Solitary Pulmonary Lesions and Their Subtypes.
    Fang T; Meng N; Feng P; Huang Z; Li Z; Fu F; Yuan J; Yang Y; Liu H; Roberts N; Wang M
    J Magn Reson Imaging; 2022 May; 55(5):1376-1390. PubMed ID: 34723413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editorial for "Amide Proton Transfer-Weighted Imaging and Multiple Models Intravoxel Incoherent Motion Based
    Chen BB; Huang YS
    J Magn Reson Imaging; 2024 Jul; 60(1):136-137. PubMed ID: 37792393
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative Study of Amide Proton Transfer-Weighted Imaging and Intravoxel Incoherent Motion Imaging in Breast Cancer Diagnosis and Evaluation.
    Meng N; Wang XJ; Sun J; Huang L; Wang Z; Wang KY; Wang J; Han DM; Wang MY
    J Magn Reson Imaging; 2020 Oct; 52(4):1175-1186. PubMed ID: 32369256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amide proton transfer-weighted imaging and stretch-exponential model DWI based
    Meng N; Song C; Sun J; Liu X; Shen L; Zhou Y; Dai B; Yu X; Wu Y; Yuan J; Yang Y; Wang Z; Wang M
    Cancer Imaging; 2024 Mar; 24(1):33. PubMed ID: 38439101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
    Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
    Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amide Proton Transfer-Weighted Imaging and Multiple Models Diffusion-Weighted Imaging Facilitates Preoperative Risk Stratification of Early-Stage Endometrial Carcinoma.
    Meng N; Fang T; Feng P; Huang Z; Sun J; Wang X; Shang J; Wang K; Han D; Wang M
    J Magn Reson Imaging; 2021 Oct; 54(4):1200-1211. PubMed ID: 33991377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non-small cell lung cancer.
    Chen HH; Chiu NT; Su WC; Guo HR; Lee BF
    Radiology; 2012 Aug; 264(2):559-66. PubMed ID: 22692034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-FDG PET/CT and circulating tumor cells in treatment-naive patients with non-small-cell lung cancer.
    Zhang F; Wu X; Zhu J; Huang Y; Song X; Jiang L
    Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3250-3259. PubMed ID: 33630146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer.
    Liao S; Penney BC; Wroblewski K; Zhang H; Simon CA; Kampalath R; Shih MC; Shimada N; Chen S; Salgia R; Appelbaum DE; Suzuki K; Chen CT; Pu Y
    Eur J Nucl Med Mol Imaging; 2012 Jan; 39(1):27-38. PubMed ID: 21946983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Volume-based parameters of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography improve outcome prediction in early-stage non-small cell lung cancer after surgical resection.
    Hyun SH; Choi JY; Kim K; Kim J; Shim YM; Um SW; Kim H; Lee KH; Kim BT
    Ann Surg; 2013 Feb; 257(2):364-70. PubMed ID: 22968069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of Simultaneous
    Huang Z; Li X; Wang Z; Meng N; Fu F; Han H; Li D; Bai Y; Wei W; Fang T; Feng P; Yuan J; Yang Y; Wang M
    J Magn Reson Imaging; 2022 Jul; 56(1):63-74. PubMed ID: 34888990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between
    Du S; Sun H; Gao S; Xin J; Lu Z; Chen Z; Pan S; Guo Q
    Clin Radiol; 2019 Mar; 74(3):178-186. PubMed ID: 30545566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary tumor standardized uptake value (SUVmax) measured on
    Hui Z; Wei F; Ren H; Xu W; Ren X
    J Cancer Res Clin Oncol; 2020 Oct; 146(10):2595-2605. PubMed ID: 32494919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Volume-based parameters measured by using FDG PET/CT in patients with stage I NSCLC treated with stereotactic body radiation therapy: prognostic value.
    Satoh Y; Onishi H; Nambu A; Araki T
    Radiology; 2014 Jan; 270(1):275-81. PubMed ID: 24029640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The increment in standardized uptake value determined using dual-phase 18F-FDG PET is a promising prognostic factor in non-small-cell lung cancer.
    Chen HH; Lee BF; Su WC; Lai YH; Chen HY; Guo HR; Yao WJ; Chiu NT
    Eur J Nucl Med Mol Imaging; 2013 Oct; 40(10):1478-85. PubMed ID: 23744342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The utility of
    Kitajima K; Kawanaka Y; Komoto H; Minami T; Yokoi T; Kuribayashi K; Kijima T; Nakamura A; Hashimoto M; Kondo N; Hasegawa S; Yamakado K
    Hell J Nucl Med; 2021; 24(3):186-198. PubMed ID: 34901959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.